Los programas de reducción de daños son esenciales en Kirguistán, donde, de las 6.402 personas registradas que viven con el VIH, el 51,5 por ciento se inyectan drogas.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas. 

By Anastasia Bezverkha

A new documentary, Stay Together to Stay Alive, offers a glimpse into the world of harm reduction in Kyrgyzstan. The film focuses on how non-government organisations are ensuring sustainable state funding for harm reduction programmes in the country.

In recent decades, Kyrgyzstan has become known among some activist groups as the “pioneer of harm reduction” in the region. The Kyrgyz government was the first in the Central Asian region to introduce such strategies, including needle syringe programmes (NSPs) and opioid substitution therapy (OST). In an unusually progressive move for the region, the state also provides OST to 450 inmates who use opioids on a daily basis.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Flickr CC Needles Harm Reduction Exchange Asia